Board Meetings for MANGALAM
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| MANGALAM | Mangalam Drugs And Organics Limited | 14 Nov 2014 | Results | Inter-alia to consider and take on record Unaudited Financial results for the Quater ended September 30,2014. | - |
| MANGALAM | Mangalam Drugs And Organics Limited | 12 Aug 2014 | Results | Inter Alia to consider and take on record Unaudited Financial Results for the quarter ended June 30, 2014. Further, in accordance with Code of Conduct for Prevention of Insider Trading framed by the Company pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) regulations, 1992, the trading window for dealing in the securities of the Company will be closed for all Directors, officers and designated employees of the Company from July 28, 2014 and would open 24 hours after the announcement of financial results to the public. | - |
| MANGALAM | Mangalam Drugs And Organics Limited | 29 May 2014 | Results | inter alia, to transact following business: (1) To consider and approve the audited quarterly financial results of the Company for the quarter ended March 31, 2014, the audited financial results of the Company for the financial year ended March 31, 2014. Further in accordance with Code of Conduct for Prevention of Insider Trading framed by the Company pursuant to the Securities and Exchange Board of India (Prohibition of insider Trading) Regulations, 1992, the trading window for dealing in the securities of the Company6 will be closed for all directors, officers and designated employees of the Company from May 15, 2014 and would open 24 hours after announcement of financial result to the public. | - |
| MANGALAM | Mangalam Drugs And Organics Limited | 13 Feb 2014 | Results | Inter-alia to consider and take on record Unaudited Financial Results for the quarter ended December 31, 2013. | - |
| MANGALAM | Mangalam Drugs And Organics Limited | 14 Nov 2013 | Results | Inter-alia to consider and take on record Unaudited Financial results for the Quater ended September 30,2013 | - |
| MANGALAM | Mangalam Drugs And Organics Limited | 13 Aug 2013 | Results | Inter-alia to consider and take on record Unaudited Financial Results for the quarter ended June 30, 2013. | - |
| MANGALAM | Mangalam Drugs And Organics Limited | 23 May 2013 | Results | To consider and approve the audited financial results for the year ended March 31, 2013. | - |
| MANGALAM | Mangalam Drugs And Organics Limited | 12 Feb 2013 | Results | Inter-alia to consider and take on record Unaudited Financial Results for the quarter ended December 31, 2012. | - |
| MANGALAM | Mangalam Drugs And Organics Limited | 08 Nov 2012 | Un-audited Financial Results | Inter-alia to consider and take on record Unaudited Financial Results for the quarter ended September 30, 2012. | - |
| MANGALAM | Mangalam Drugs And Organics Limited | 13 Aug 2012 | Un-audited Financial Results | Inter-alia to consider and take on record Unaudited Financial Results for the quarter ended June 30, 2012. | - |
| MANGALAM | Mangalam Drugs And Organics Limited | 23 Jul 2012 | Results/Dividend | Inter-alia to consider and approve the audited financial results for the year ended March 31, 2012 and to recommend dividend, if any | - |
| MANGALAM | Mangalam Drugs And Organics Limited | 19 May 2012 | Un-audited Financial Results | Inter-alia to consider and take on record Unaudited Financial Results for the quarter ended March 31, 2012. | - |
| MANGALAM | Mangalam Drugs And Organics Limited | 13 Feb 2012 | Un-audited Financial Results | Inter-alia to consider and take on record Unaudited Financial Results for the quarter ended December 31, 2011. | - |
| MANGALAM | Mangalam Drugs And Organics Limited | 12 Aug 2011 | Un-audited Financial Results | Inter-alia to consider and take on record Unaudited Financial Results for the quarter ended June 30, 2011. | - |
| MANGALAM | Mangalam Drugs And Organics Limited | 30 May 2011 | Results/Dividend | Inter alia, to consider and approve the Audited Financial Results for the year ended March 31, 2011 and to recommend dividend, if any. | - |